Fertility and Sterility
Volume 90, Issue 3 , Pages 709-713 , September 2008

Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome

  • Hirotaka Ota, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Akita Red Cross Hospital, Akita, Japan
    • Corresponding Author InformationReprint requests: Hirotaka Ota, M.D., 222-1 Kamikitade Saruta Aza Naeshirosawa, Akita-city, Akita-ken 010-1495, Japan (FAX: 81-18-829-5255).
    • ,
  • Takashi Goto, M.D.

      Affiliations

    • Department of Internal Medicine, Division of Metabolic Disorder, Akita Red Cross Hospital, Akita, Japan
    • ,
  • Tomomi Yoshioka, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Akita Red Cross Hospital, Akita, Japan
    • ,
  • Noriaki Ohyama, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Akita Red Cross Hospital, Akita, Japan

Received 13 September 2006 ,Revised 10 January 2007 ,Accepted 10 January 2007.

References 

  1. Lobo RA, Paul W, March CM, Granger L, Kletzky OA. Clomiphene and dexamethasone in women unresponsive to clomiphene alone. Obstet Gynecol. 1982;60:497–501
  2. Singh KB, Dunnihoo DR, Mahajan DK, Bairnsfather LE. Clomiphene-dexamethasone treatment of clomiphene-resistant women with and without the polycystic ovary syndrome. J Reprod Med. 1992;37:215–218
  3. Ng EHY, Wat NMS, Ho PC. Effects of metformin on ovulation rate, hormonal and metabolic profiles in women with clomiphene-resistant polycystic ovaries: a randomized, double-blinded placebo-controlled trial. Hum Reprod. 2001;8:1625–1631
  4. Lachelin GCL, Judd HL, Swanson SC, Hauck ME, Parker DC, Yen SSC. Long-term effects of nightly dexamethasone administration in patients with polycystic ovarian disease. J Clin Endocrinol Metab. 1982;55:768–773
  5. Carmina E, Lobo RA. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism. Obstet Gynecol. 1991;78:845–849
  6. Parsanezhad ME, Alborzi S, Motazedian S, Omrani G. Use of damethasone and clomiphene citrate in the treatment of clomiphene citrate-resistant patients with polycystic ovary syndrome and normal dehydroepiandrosterone sulfate levels: a prospective, double-blind, placebo-controlled trial. Fertil Steril. 2002;78:1001–1004
  7. Brettenthaler N, de Geyter C, Huber PR, Keller U. Effect of the insulin sensitizer pioglitazone on insulin resistance, hyperandrogenism, and ovulatory dysfunction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89:3835–3840
  8. Glueck CJ, Wang P, Fontaine R, Tracy T, Sieve-Smith L. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome. Metabolism. 1999;48:511–519
  9. Velázquez EM, Acosta A, Mendoza SG. Menstrual cyclicity after metformin therapy in polycystic ovary syndrome. Obstet Gynecol. 1997;90:392–395
  10. Nestler JE, Jakubowicz DJ, Evans WS, Pasquali RP. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 1998;338:1876–1880
  11. Glueck CJ, Moreira A, Goldenberg N, Sieve L, Wang P. Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin. Hum Reprod. 2003;8:1618–1625
  12. Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;29:574–579
  13. Smith U. Pioglitazone: mechanism of action. Int J Clin Pract. 2001;121(Suppl):13–18
  14. Ishibashi M, Egashira K, Hiasa K, Inoue S, Ni W, Zhao Q, et al. Antiinflammatory and antiarteriosclerotic effects of pioglitazone. Hypertension. 2002;40:687–693
  15. Kawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: a rational approach. In:  Dunaif A,  Givens JR,  Haselitime F,  Merriam GR editor. Polycystic ovary syndrome. Cambridge, MA: Blackwell; 1992;p. 377–384
  16. Glueck CJ, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod. 2002;17:2858–2864
  17. Trott EA, Plouffe L, Hansen K, Hines R, Brann DW, Mahesh VB. Ovulation induction in clomiphene-resistant anovulatory women with normal DHEAS levels: beneficial effects the addition of dexamethasone during the follicular phase. Fertil Steril. 1996;66:484–486
  18. Schröder AK, Tauchber S, Ortmann O, Diedrich K, Weiss JM. Insulin resistance in patients with polycystic ovary syndrome. Ann Med. 2004;36:426–439
  19. Costello MF, Eden J. A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertil Steril. 2003;1:1–13
  20. Baillargeon J-P, Jakubowicz DJ, Luorno MJ, Jakubowicz S, Nestler JE. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril. 2004;82:893–902
  21. Romualdi D, Guido M, Ciampelli M, Giuliani M, Leoni F, Perri C, et al. Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome. Hum Reprod. 2003;18:1210–1218
  22. Coffler MS, Patel K, Dahan MH, Yoo RY, Malcom PJ, Chang RJ. Enhanced granulosa cell responsiveness to follicle-stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone. J Clin Endocrinol Metab. 2003;88:5624–5631
  23. Glueck CJ, Philips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study. Fertil Steril. 2001;75:46–52
  24. Arlt W, Auchus JR, Miller WL. Thiazolidinediones but not metformin directly inhibit the steriodogenic enzymes P450c17 and 3β-hydroxysteroid dehydrogenase. J Biol Chem. 2001;276:16767–16771
  25. Veldhuis JD, Zhang G, Garmey JC. Troglitazone, an insulin-sensitizing thiazolidinedione, represses combined stimulation by LH and insulin of de novo androgen biosynthesis by thecal cells in vitro. J Clin Endocrinol Metab. 2002;87:1129–1133
  26. Mitwallly MFM, Witchel SF, Casper RF. Troglitazone: a possible modulator of ovarian steroidogenesis. J Soc Gynecol Investig. 2002;9:163–167
  27. Schoppee PD, Garmey JC, Veldhuis JD. Putative activation of the peroxisome proliferator-activated receptor γ impairs androgen and enhances progesterone biosynthesis in primary cultures of porcine theca cells. Biol Reprod. 2002;66:190–198
  28. Attia GR, Rainey WE, Carr BR. Metformin directly inhibits androgen production in human thecal cells. Fertil Steril. 2001;76:517–524

PII: S0015-0282(07)00282-8

doi: 10.1016/j.fertnstert.2007.01.117

Fertility and Sterility
Volume 90, Issue 3 , Pages 709-713 , September 2008

Article Tools